Julié Catherine, Boyé Karine, Desgrippes Arnaud, Régnier Agathe, Staroz Frédéric, Fontaine Eric, Franc Brigitte
Department of Pathology, Ambroise Paré Hospital, Boulogne, France.
Pathol Res Pract. 2002;198(2):115-20. doi: 10.1078/0344-0338-00197.
Endocervicosis of the urinary bladder is a rare non-neoplastic condition characterized by endocervical-type glands deeply situated in the urinary bladder wall of women of reproductive age. We compared the immunohistochemical phenotype of a case of endocervicosis in a 35-year-old woman with four normal uterine endocervices. We tested antibodies known as reactive in the uterus and not mentioned or negative in the urothelium (HBME-1, estrogen receptor (ER), progesterone receptors (PR), DF3, Chromogranin). The proliferative index was assessed with MIB-1 antibody. Endocervicosis glands displayed stronger expression of HBME-1, ER and PR than normal endocervices, while the urothelium was negative. There was no difference in DF3 expression. The number of Chromogranin-positive cells was higher in endocervicosis than in the endocervices. The proliferative index was higher in the endocervicosis glands (15%) than in the normal endocervices (mean 3%), but was within the normal range established for endocervical glands. Our results confirm the endocervical nature of endocervicosis and constitute further arguments for the mullerian origin hypothesis. The only modestly increased proliferative index, as compared to endocervical malignancies, is consistent with a benign diagnosis.
膀胱宫颈内膜异位症是一种罕见的非肿瘤性疾病,其特征是在育龄期女性的膀胱壁深处存在宫颈内膜样腺体。我们将一名35岁女性的膀胱宫颈内膜异位症病例的免疫组化表型与四个正常子宫颈内膜进行了比较。我们检测了在子宫中呈反应性而在尿路上皮中未提及或呈阴性的抗体(HBME-1、雌激素受体(ER)、孕激素受体(PR)、DF3、嗜铬粒蛋白)。用MIB-1抗体评估增殖指数。膀胱宫颈内膜异位症腺体中HBME-1、ER和PR的表达比正常宫颈内膜更强,而尿路上皮呈阴性。DF3表达无差异。膀胱宫颈内膜异位症中嗜铬粒蛋白阳性细胞数量比宫颈内膜多。膀胱宫颈内膜异位症腺体的增殖指数(15%)高于正常宫颈内膜(平均3%),但在宫颈内膜腺体的正常范围内。我们的结果证实了膀胱宫颈内膜异位症的宫颈内膜性质,并为苗勒管起源假说提供了进一步的论据。与宫颈恶性肿瘤相比,仅增殖指数略有增加,这与良性诊断相符。